$959 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 82 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | BAKKT HOLDINGS INCcall | $0 | – | -30,000 | -100.0% | -0.03% | – | |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INcall | $0 | – | -150,000 | -100.0% | -0.17% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -100,000 | -100.0% | -0.19% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -65,000 | -100.0% | -0.34% | – |
| RAPT | Exit | RAPT THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.42% | – |
| OSTK | Exit | OVERSTOCK COM INC DELcall | $0 | – | -70,000 | -100.0% | -0.48% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -55,555 | -100.0% | -0.59% | – |
| GS | Exit | GOLDMAN SACHS GROUP INC | $0 | – | -18,000 | -100.0% | -0.79% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -135,000 | -100.0% | -0.82% | – |
| PANW | Exit | PALO ALTO NETWORKS INCput | $0 | – | -14,700 | -100.0% | -0.94% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -25,000 | -100.0% | -0.97% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -27,889 | -100.0% | -1.12% | – |
| HAE | Exit | HAEMONETICS CORP MASScall | $0 | – | -200,000 | -100.0% | -1.22% | – |
| JCI | Exit | JOHNSON CTLS INTL PLC | $0 | – | -132,600 | -100.0% | -1.24% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INCput | $0 | – | -150,000 | -100.0% | -1.29% | – |
| APO | Exit | APOLLO GLOBAL MGMT INC | $0 | – | -155,000 | -100.0% | -1.29% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -50,000 | -100.0% | -1.46% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -99,200 | -100.0% | -1.54% | – |
| UAA | Exit | UNDER ARMOUR INCcl a | $0 | – | -697,000 | -100.0% | -1.70% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -45,509 | -100.0% | -1.72% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -77,300 | -100.0% | -1.95% | – |
| ACGL | Exit | ARCH CAP GROUP LTDord | $0 | – | -400,000 | -100.0% | -2.04% | – |
| AVY | Exit | AVERY DENNISON CORP | $0 | – | -97,847 | -100.0% | -2.44% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -94,000 | -100.0% | -2.59% | – |
| HUM | Exit | HUMANA INC | $0 | – | -57,029 | -100.0% | -3.04% | – |
| RNR | Exit | RENAISSANCERE HLDGS LTD | $0 | – | -175,000 | -100.0% | -3.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.